Carolyn Sharrock-Dorsten, DPM
Podiatrist · Bryan, OHNPI 1659325157
Payments from drug & device makers
What this record shows
This record is dominated by travel and lodging: $10,128 of the $16,126 with a category attached, or 62.8%. 15 manufacturers reported payments, led by Treace Medical Concepts, Inc. at 41.2% of the total. Reporting peaked in 2023 at $4,182 and has fallen 56.6% since, to $1,817 in 2025. Among podiatrist clinicians in OH with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 59 payments — averaging $273.32 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Treace Medical Concepts, Inc.$7K
- Paragon 28, Inc.$4K
- Biotissue Holdings Inc.$2K
- In2bones USA, LLC$2K
- Trimed, Inc.$1K
- Organogenesis Inc.$190
- plus $409 from 9 others
What the payments were for
- Consulting fees$3,60022%
- Travel & lodging$10,12863%
- Food & beverage$2,39815%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Treace Medical Concepts, Inc. | 18 | $6,638 |
| Paragon 28, Inc. | 16 | $4,395 |
| Biotissue Holdings Inc. | 2 | $1,653 |
| In2bones USA, LLC | 1 | $1,500 |
| Trimed, Inc. | 2 | $1,340 |
| Organogenesis Inc. | 2 | $190 |
| Smith+Nephew | 1 | $122 |
| Novo Nordisk | 5 | $75 |
| Stryker(2 entities) | 3 | $61 |
| Merck | 3 | $43 |
| Rock Medical Orthopedics, Inc. | 2 | $43 |
| Celularity Inc. | 1 | $20 |
| Sanofi-aventis U.S. LLC | 1 | $19 |
| Lilly USA, LLC | 1 | $13 |
| Boehringer Ingelheim | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Lapiplasty System$4,581
- Portfolio$2,630
- AlloAid Allograft$1,500
- Reference Toe System$1,500
- NEOX$1,327
- CLARIX$1,327
- Product Portfolio$1,128
- LAPIPLASTY SYSTEM 1$858
- Lapiplasty$680
- Bun-Yo-Matic$501
- Apligraf$169
- Stravix$122
- Grafix$122
- GRAFIX PL$122
- Grafix XC$122
How this compares
$16,126 in reported general payments places this provider in the 95th percentile of 397 podiatrist providers in Ohio.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Neomycin-Polymyxin-HcNeomycin/Polymyxin B/Hydrocort | 59 | $3,136 |
| Ibuprofen | 53 | $794 |
| Gabapentin | 53 | $744 |
| Gentamicin Sulfate | 16 | $670 |
| Cephalexin | 102 | $582 |
| Nitro-BidNitroglycerin | 11 | $581 |
| Clindamycin Hcl | 47 | $514 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 56 | $289 |
| SsdSilver Sulfadiazine | 31 | $189 |
| Allopurinol | 19 | $132 |
| Ciprofloxacin Hcl | 14 | $131 |
| Prednisone | 53 | $123 |
| Silver Sulfadiazine | 18 | $115 |
| Meloxicam | 54 | $104 |
| Methylprednisolone | 14 | $94 |
Paid to pharmacies, not to this prescriber.
Other podiatrist in Bryan
- Mark HardyAvon$2.1M
- Lawrence DidomenicoBoardman$1.1M
- Ralph NapolitanoNew Albany$494K
- Thomas GronerNiles$193K
- Michael MaierCleveland$120K
- Eric StortsLondon$101K
- Daniel LoganGahanna$83K
- Howard KimmelBrookpark$67K
- James HayesCleveland$31K
- Nathan RossiCleveland$31K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.